North American Morning Briefing: Futures Pause -2-
All times in GMT. Powered by Kantar Media and Dow Jones.
Expected Earnings for Friday
Amrep Corp (AXR) is expected to report for 2Q.
Canadian Western Bank (CWB.T) is expected to report $0.86 for 4Q.
Clearday Inc (CLRD) is expected to report for 3Q.
Ferrellgas Partners LP (FGPR) is expected to report for 1Q.
Franklin Resources Inc (BEN) is expected to report.
Johnson Outdoors (JOUT) is expected to report $-0.32 for 4Q.
Sigmatron International Inc (SGMA) is expected to report for 2Q.
Value Line (VALU) is expected to report for 2Q.
Virco Manufacturing Corp (VIRC) is expected to report for 3Q.
Vyant Bio Inc (VYNT) is expected to report for 3Q.
Powered by Kantar Media and Dow Jones.
ANALYST RATINGS ACTIONS
5E Advanced Materials Cut to Neutral From Buy by B. Riley Securities
Alkami Technology Cut to Equal-Weight From Overweight by Stephens & Co.
Biogen Raised to Outperform From Market Perform by Raymond James
Bioventus Raised to Buy From Hold by Canaccord Genuity
Cerevel Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Cerevel Therapeutics Cut to Neutral From Overweight by Cantor Fitzgerald
Cerevel Therapeutics Cut to Neutral From Overweight by Piper Sandler
ChargePoint Cut to Neutral From Buy by B. Riley Securities
Danaher Cut to Neutral From Buy by Goldman Sachs
Datadog Raised to Buy From Hold by Stifel
Duckhorn Portfolio Cut to Neutral From Buy by B of A Securities
FMC Corporation Cut to Neutral From Buy by Mizuho
Hepion Pharmaceuticals Cut to Hold From Buy by Brookline Capital
IGM Biosciences Cut to Neutral From Buy by HC Wainwright & Co.
JB Hunt Raised to Neutral From Sell by UBS
Q2 Holdings Raised to Overweight From Equal-Weight by Stephens & Co.
Schneider National Raised to Equal-Weight From Underweight by Wells Fargo
Sphere Entertainment Raised to Buy From Neutral by Seaport Global
Sprinklr Cut to Neutral From Buy by BTIG
Take-Two Interactive Cut to Neutral From Buy by B of A Securities
VistaGen Therapeutics Raised to Buy From Hold by Jefferies
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
December 08, 2023 06:20 ET (11:20 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth